1. Home
  2. HROW vs EOI Comparison

HROW vs EOI Comparison

Compare HROW & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • EOI
  • Stock Information
  • Founded
  • HROW 1998
  • EOI 2004
  • Country
  • HROW United States
  • EOI United States
  • Employees
  • HROW N/A
  • EOI N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • EOI Finance/Investors Services
  • Sector
  • HROW Health Care
  • EOI Finance
  • Exchange
  • HROW Nasdaq
  • EOI Nasdaq
  • Market Cap
  • HROW 1.0B
  • EOI 827.9M
  • IPO Year
  • HROW N/A
  • EOI N/A
  • Fundamental
  • Price
  • HROW $24.98
  • EOI $18.85
  • Analyst Decision
  • HROW Strong Buy
  • EOI
  • Analyst Count
  • HROW 5
  • EOI 0
  • Target Price
  • HROW $58.40
  • EOI N/A
  • AVG Volume (30 Days)
  • HROW 691.9K
  • EOI 83.6K
  • Earning Date
  • HROW 05-12-2025
  • EOI 01-01-0001
  • Dividend Yield
  • HROW N/A
  • EOI 7.19%
  • EPS Growth
  • HROW N/A
  • EOI N/A
  • EPS
  • HROW N/A
  • EOI N/A
  • Revenue
  • HROW $199,614,000.00
  • EOI N/A
  • Revenue This Year
  • HROW $45.63
  • EOI N/A
  • Revenue Next Year
  • HROW $38.04
  • EOI N/A
  • P/E Ratio
  • HROW N/A
  • EOI N/A
  • Revenue Growth
  • HROW 53.32
  • EOI N/A
  • 52 Week Low
  • HROW $9.86
  • EOI $14.36
  • 52 Week High
  • HROW $59.23
  • EOI $18.88
  • Technical
  • Relative Strength Index (RSI)
  • HROW 41.63
  • EOI 37.20
  • Support Level
  • HROW $25.17
  • EOI $18.31
  • Resistance Level
  • HROW $30.73
  • EOI $19.68
  • Average True Range (ATR)
  • HROW 2.18
  • EOI 0.32
  • MACD
  • HROW 0.20
  • EOI 0.02
  • Stochastic Oscillator
  • HROW 31.23
  • EOI 39.42

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest

Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation.

Share on Social Networks: